Circle Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $467K | Hold |
890
| – | – | 0.01% | 170 |
|
|
2025
Q1 | $564K | Hold |
890
| – | – | 0.01% | 156 |
|
|
2024
Q4 | $634K | Hold |
890
| – | – | 0.01% | 149 |
|
|
2024
Q3 | $936K | Hold |
890
| – | – | 0.02% | 121 |
|
|
2024
Q2 | $935K | Sell |
890
-5
| -0.6% | -$5.26K | 0.02% | 100 |
|
|
2024
Q1 | $861K | Hold |
895
| – | – | 0.02% | 106 |
|
|
2023
Q4 | $786K | Sell |
895
-7
| -0.8% | -$6.15K | 0.02% | 103 |
|
|
2023
Q3 | $742K | Buy |
902
+257
| +40% | +$212K | 0.02% | 99 |
|
|
2023
Q2 | $463K | Sell |
645
-2
| -0.3% | -$1.44K | 0.06% | 107 |
|
|
2023
Q1 | $532K | Buy |
647
+2
| +0.3% | +$1.64K | 0.08% | 92 |
|
|
2022
Q4 | $465K | Buy |
645
+10
| +2% | +$7.22K | 0.07% | 101 |
|
|
2022
Q3 | $437K | Sell |
635
-10
| -2% | -$6.88K | 0.07% | 108 |
|
|
2022
Q2 | $381K | Hold |
645
| – | – | 0.06% | 122 |
|
|
2022
Q1 | $450K | Hold |
645
| – | – | 0.06% | 129 |
|
|
2021
Q4 | $407K | Buy |
+645
| New | +$407K | 0.05% | 137 |
|
|
2021
Q1 | – | Sell |
-3,675
| Closed | -$1.78M | – | 211 |
|
|
2020
Q4 | $1.78M | Hold |
3,675
| – | – | 0.25% | 44 |
|
|
2020
Q3 | $2.06M | Sell |
3,675
-8
| -0.2% | -$4.48K | 0.34% | 34 |
|
|
2020
Q2 | $2.3M | Sell |
3,683
-1,396
| -27% | -$871K | 0.4% | 34 |
|
|
2020
Q1 | $2.48M | Sell |
5,079
-239
| -4% | -$117K | 0.48% | 32 |
|
|
2019
Q4 | $2M | Sell |
5,318
-52
| -1% | -$19.5K | 0.35% | 32 |
|
|
2019
Q3 | $1.49M | Sell |
5,370
-50
| -0.9% | -$13.9K | 0.32% | 39 |
|
|
2019
Q2 | $1.7M | Sell |
5,420
-890
| -14% | -$278K | 0.37% | 33 |
|
|
2019
Q1 | $2.59M | Buy |
+6,310
| New | +$2.59M | 0.58% | 21 |
|